Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process-Reference-Cited by-同舟云学术

Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process

Published:2017-03-31 Issue:6 Volume:26 Page:694-701
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Kesselheim Aaron S.¹,Gagne Joshua J.¹,Franklin Jessica M.¹^ORCID,Eddings Wesley¹,Fulchino Lisa A.¹,Campbell Eric G.¹

Affiliation:

1. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine; Brigham and Women's Hospital (ASK, JMF, WE, LAF, JJG) and the Mongan Institute for Health Policy, Massachusetts General Hospital (EGC), Harvard Medical School in Boston; MA USA

Funder

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference44 articles.

1. Definition and classification of generic drugs across the world;Alfonso-Cristancho;Appl Health Econ Health Policy,2015

2. Value-based benefit design: using a predictive modeling approach to improve compliance;Mahoney;J Manag Care Pharm,2008

3. FDA Generic competition and drug prices 2015 http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm129385.htm

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. US state laws on medical freedom and investigational stem cell procedures: a call to focus on state-based legislation;Cytotherapy;2024-04

2. Trust in the approval process of medicines mediates the effect of an educational intervention on the pain relief induced by a generic analgesic;Research in Social and Administrative Pharmacy;2023-08

3. When consumers lose power: An examination of the stakeholder dynamics in the pharmaceutical industry;Business Ethics, the Environment & Responsibility;2023-04-26

4. State Laws and Generic Substitution in the Year After New Generic Competition;Value in Health;2022-10

5. Experts’ Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care;Journal of General Internal Medicine;2022-02-09